Patent · US Active

Hepatitis C virus non-structural NS3/4A fusion gene

US7439347B2 · kind B2 · utility

5Cited by

85References

70Claims

0Family size

Assignee

TRIPEP AB · SE

Inventor

Matti Sallberg · Stockholm, SE

Key dates

Filing date	Oct 13, 2005
Grant date	Oct 21, 2008
Priority date	—
Expiry date	Aug 17, 2026

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A90/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein is the discovery of a novel hepatitis C virus (HCV) isolated from a human patient. Embodiments of the invention include HCV peptides, nucleic acids encoding said HCV peptides, antibodies directed to said peptides, compositions containing said nucleic acids and peptides, as well as, methods of making and using the aforementioned compositions including, but not limited to, diagnostics and medicaments for the treatment and prevention of HCV infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.